Ophthalmology – Papilledema

Basics

Description

Papilledema is optic disc swelling caused specifically by elevated intracranial pressure (ICP).

It is usually:

• Bilateral
• Relatively symmetric

but may be:

• Markedly asymmetric
• Rarely apparently unilateral

Papilledema is a sign rather than a diagnosis. The underlying cause of raised ICP must be identified.

Clinical Importance

Papilledema may signal a potentially life-threatening disorder, including:

• Intracranial mass lesion
• Cerebral venous sinus thrombosis (CVST)
• Hydrocephalus
• Meningitis or encephalitis
• Intracranial hemorrhage
• Severe cerebral edema

Therefore:

New true papilledema requires urgent neurologic evaluation and neuroimaging.

Papilledema vs Optic Disc Edema

These terms should not be used interchangeably.

Papilledema

Optic disc edema specifically due to:

Raised ICP

Other Causes of Optic Disc Edema

Include:

• Optic neuritis
• NAION
• AAION
• Neuroretinitis
• Infiltrative optic neuropathy
• Compressive optic neuropathy
• Malignant hypertension

Epidemiology

The epidemiology depends on the underlying cause.

A common cause encountered in neuro-ophthalmology is:

Idiopathic intracranial hypertension (IIH)

IIH most commonly affects:

• Women of reproductive age
• Patients with obesity
• Patients with recent weight gain

However, IIH can occur outside this classic demographic.

Pediatric Considerations

Before puberty:

• IIH has less female predominance
• Obesity is a less consistent association

After puberty, the demographic pattern becomes more similar to adults.

Risk Factors for IIH

Important associations include:

• Obesity
• Recent weight gain
• Female sex after puberty
• Obstructive sleep apnea

Drugs associated with intracranial hypertension include:

• Tetracyclines
• Vitamin A derivatives / retinoids
• Growth hormone
• Lithium in selected cases

Medication history should be reviewed carefully.

Risk Factors for CVST

Important risk factors include:

• Pregnancy and postpartum state
• Estrogen-containing contraception
• Hypercoagulable disorders
• Malignancy
• Systemic infection
• Severe dehydration
• Inflammatory disease

CVST may cause:

• Papilledema
• Stroke
• Seizure
• Intracranial hemorrhage

Pathophysiology

Raised CSF pressure is transmitted through the subarachnoid space surrounding the optic nerve.

This causes:

Elevated retrolaminar pressure → impaired axoplasmic transport → axonal swelling

Secondary effects include:

• Venous congestion
• Capillary leakage
• Hemorrhage
• Peripapillary folds

With prolonged disease:

• Axons are lost
• Optic atrophy develops
• Permanent visual loss may occur

Monro-Kellie Principle

Intracranial volume is composed mainly of:

• Brain tissue
• Blood
• CSF

Because the cranial vault is relatively fixed, expansion of one component without adequate compensation can elevate ICP.

Etiology

Important causes include:

• Idiopathic intracranial hypertension
• Cerebral venous sinus thrombosis
• Intracranial mass
• Hydrocephalus
• Meningitis
• Encephalitis
• Intracranial hemorrhage
• Cerebral edema
• Craniosynostosis
• Venous outflow obstruction
• Rare spinal cord or spinal subarachnoid lesions

Idiopathic Intracranial Hypertension

IIH is raised ICP without an identifiable structural, vascular, or CSF cause.

Historically called:

Pseudotumor cerebri

Diagnostic Features of IIH

Typical criteria include:

• Papilledema
• Otherwise normal neurologic examination except possible cranial nerve abnormalities, especially CN VI palsy
• Neuroimaging showing no mass or hydrocephalus
• Normal CSF composition
• Elevated lumbar puncture opening pressure

In adults, an opening pressure around:

≥25 cm H₂O

supports the diagnosis when measured correctly and interpreted in context.

History

Ask about symptoms of:

• Raised ICP
• Underlying neurologic disease
• Venous thrombosis
• Infection

Important symptoms include:

• Headache
• Nausea
• Vomiting
• Pulsatile tinnitus
• Transient visual obscurations
• Diplopia
• Progressive visual loss

Headache

Headache is common but nonspecific.

It may be:

• Daily or near-daily
• Worse on awakening
• Worse when lying flat
• Worse with coughing or Valsalva
• Migraine-like

Importantly:

Headache severity does not reliably predict the severity of papilledema or visual loss.

Pulsatile Tinnitus

A classic symptom is:

Pulse-synchronous whooshing tinnitus

It is thought to relate to turbulent venous flow.

Transient Visual Obscurations

Patients may experience brief episodes of:

• Graying
• Dimming
• Blackout of vision

usually lasting:

Seconds

Often triggered by:

• Standing
• Bending
• Position change

These are strongly associated with optic disc swelling but do not themselves indicate permanent visual loss.

Diplopia

Diplopia most commonly results from:

Sixth nerve palsy

which may be:

• Unilateral
• Bilateral

CN VI palsy is a classic false-localizing sign of raised ICP.

Visual Acuity

In early papilledema:

Central visual acuity is often normal

Reduced acuity may indicate:

• Advanced papilledema
• Macular edema
• Choroidal folds
• Another optic neuropathy

Color Vision

Usually preserved early.

Progressive dyschromatopsia suggests:

• Optic nerve dysfunction
• Axonal injury
• Advanced disease

Pupils

Pupillary responses are generally normal early.

A RAPD may occur when papilledema or optic nerve injury is:

• Markedly asymmetric

Visual Fields

Early abnormalities commonly include:

• Enlarged blind spot
• Nasal defects
• Arcuate defects

Progressive disease may produce:

• Nasal step
• Peripheral constriction
• Generalized depression
• Central loss in advanced cases

Serial automated perimetry is crucial for monitoring.

Fundus Findings

Early papilledema may show:

• Blurring of disc margins
• RNFL opacification
• Loss of physiologic cup
• Vessel obscuration at the disc edge
• Disc elevation

Spontaneous Venous Pulsation

Loss of spontaneous venous pulsation may occur with elevated ICP.

However:

Absence of spontaneous venous pulsation is not diagnostic, because it may also be absent in normal individuals.

Visible spontaneous venous pulsation makes markedly elevated ICP less likely but does not absolutely exclude it.

Moderate Papilledema

More advanced findings include:

• Disc hyperemia
• Increased elevation
• Venous engorgement
• Peripapillary hemorrhages
• Cotton-wool spots
• Hard exudates
• Retinal folds

Paton Lines

Paton lines are concentric folds around the optic nerve caused by mechanical distortion of the peripapillary retina.

They are characteristic of significant optic disc swelling.

Choroidal Folds

Papilledema may produce:

• Horizontal choroidal folds
• Macular folds

These may cause:

• Metamorphopsia
• Reduced visual acuity

Macular Star

Hard exudates may occasionally form a:

Macular star

This may mimic neuroretinitis.

The overall clinical context is important.

Severe Papilledema

Severe disease may produce:

• Extensive hemorrhages
• Subhyaloid hemorrhage
• Vitreous hemorrhage
• Retinal vascular occlusion
• Macular edema

Chronic Papilledema

Long-standing papilledema may eventually lead to:

• Optic disc pallor
• Gliosis
• RNFL thinning
• Permanent visual field loss
• Optic atrophy

An important point:

An atrophic optic nerve may stop swelling even when ICP remains elevated.

Thus, disappearance of disc edema does not always mean successful treatment.

Frisén Grading

Papilledema can be graded using the:

Frisén scale

ranging from:

Grade 0 to Grade 5

It provides a semiquantitative description of disc swelling.

Visual function must still be assessed independently with:

• Acuity
• Visual fields
• OCT

Diagnostic Approach

The evaluation should answer:

1. Is there true optic disc edema?
2. Is it due to raised intracranial pressure?
3. What is causing the raised ICP?

Neuroimaging

Urgent imaging is required before lumbar puncture in most patients with suspected papilledema.

Preferred study:

MRI brain with and without contrast

plus:

MR venography

to evaluate the cerebral venous sinuses.

Why MRV/CTV Is Important

Venous imaging helps exclude:

Cerebral venous sinus thrombosis

which may closely mimic IIH.

MRV or CTV is especially important when:

• The patient does not fit the classic IIH demographic
• Thrombotic risk factors are present
• Symptoms are acute or atypical

In modern practice, venous imaging is commonly incorporated into the workup of confirmed papilledema.

CT

CT may be used when:

• MRI is unavailable
• Emergency imaging is needed immediately

However, MRI is more sensitive for many structural causes.

MRI Findings Associated With Raised ICP

Supportive but nonspecific findings include:

• Empty or partially empty sella
• Enlarged perioptic CSF spaces
• Optic nerve tortuosity
• Posterior globe flattening
• Optic disc protrusion
• Transverse venous sinus stenosis

These findings support but do not independently establish IIH.

Venous Sinus Stenosis

Transverse sinus stenosis is common in IIH.

It may be:

• A contributor to raised ICP
• A consequence of raised ICP
• Both

Its presence alone is not diagnostic.

Lumbar Puncture

After appropriate imaging has excluded a dangerous mass or obstructive process, LP is performed to assess:

• Opening pressure
• CSF cell count
• Protein
• Glucose
• Additional infectious/inflammatory studies when indicated

Opening Pressure Technique

Opening pressure should ideally be measured:

• In lateral decubitus position
• With the patient relaxed
• Without excessive hip flexion or Valsalva
• Before significant CSF removal

A single pressure reading should always be interpreted in clinical context.

OCT

OCT is extremely useful for monitoring papilledema.

Assess:

• Peripapillary RNFL
• Optic nerve head volume
• Macular ganglion cell layer

Important OCT Principle

In active papilledema:

• RNFL becomes thick

As the edema improves:

• RNFL thickness falls

However, decreasing RNFL may mean either:

• Resolution of edema
• Development of optic atrophy

Therefore, correlate with:

• Ganglion cell analysis
• Visual fields
• Visual acuity

Fundus Photography

Serial disc photographs help document:

• Disc elevation
• Hemorrhages
• Vascular changes
• Treatment response

Optic Disc Ultrasound

B-scan ultrasonography may help distinguish papilledema from:

Optic disc drusen

Other useful modalities include:

• Enhanced-depth imaging OCT
• Fundus autofluorescence

Differential Diagnosis

Important mimics include:

• Optic disc drusen
• Crowded hyperopic discs
• Tilted discs
• Myelinated nerve fibers
• Congenital disc anomalies
• Optic neuritis
• NAION
• AAION
• Neuroretinitis
• Infiltrative optic neuropathy
• Compressive optic neuropathy
• Malignant hypertension

Papilledema vs Optic Disc Drusen

Papilledema favors:

• True edema
• Vessel obscuration
• Hyperemia
• Hemorrhage
• Symptoms of raised ICP

Optic disc drusen favors:

• Lumpy disc surface
• Little hyperemia
• Minimal hemorrhage
• Hyperreflective deposits on OCT
• Autofluorescence if superficial

Buried drusen in children can be particularly difficult to distinguish.

Treatment Principles

Treatment is directed toward:

The cause of intracranial hypertension

while preserving:

• Vision
• Neurologic function
• Life

IIH Treatment Goals

The main goals are:

1. Preserve vision
2. Reduce ICP
3. Treat headache
4. Modify disease risk factors

Weight Loss

For patients with overweight or obesity:

Weight loss is the major disease-modifying treatment for IIH.

Sustained weight reduction may:

• Lower ICP
• Improve papilledema
• Produce remission

Even modest weight loss may help, while greater sustained loss is often needed for durable control.

Bariatric Surgery

For selected patients with:

• Severe obesity
• Persistent IIH
• Inadequate response to conventional weight management

bariatric surgery can produce substantial long-term improvement.

Acetazolamide

Acetazolamide is the principal medication for IIH when papilledema or visual dysfunction is present.

Mechanism:

Decreases CSF production via carbonic anhydrase inhibition

Acetazolamide Dosing

Dose is individualized according to:

• Disease severity
• Visual field loss
• Tolerance

Treatment often begins with a modest dose and is increased as needed.

Acetazolamide Adverse Effects

Common adverse effects include:

• Paresthesias
• Fatigue
• Dysgeusia
• GI upset
• Kidney stones
• Metabolic acidosis
• Electrolyte abnormalities

Monitor:

• Renal function
• Electrolytes

when clinically appropriate.

Topiramate

Topiramate may help because it can:

• Treat migraine-type headache
• Promote weight loss
• Produce mild carbonic anhydrase inhibition

Potential adverse effects include:

• Cognitive slowing
• Paresthesias
• Mood change
• Nephrolithiasis

It can rarely cause:

Acute bilateral angle closure with myopic shift

Furosemide

May occasionally be used as an adjunct when:

• Acetazolamide is not tolerated
• Additional ICP reduction is required

Evidence is less robust.

Corticosteroids

Corticosteroids are not routine long-term treatment for IIH.

They may:

• Cause weight gain
• Produce systemic toxicity
• Cause rebound raised ICP during withdrawal

They remain useful for selected underlying causes such as:

• Vasogenic edema from certain brain tumors
• Inflammatory CNS disease

Serial Lumbar Punctures

Repeated LPs are not recommended for routine long-term treatment because CSF is rapidly replaced.

They may occasionally be used as a temporary bridge while:

• Definitive treatment is arranged
• Pregnancy limits other options

Fulminant IIH

Fulminant IIH involves:

• Rapidly developing severe papilledema
• Rapid visual deterioration

This is a neuro-ophthalmic emergency.

Urgent treatment may require:

• Optic nerve sheath fenestration
• CSF diversion
• Other rapid ICP-lowering intervention

Optic Nerve Sheath Fenestration

ONSF reduces pressure around the optic nerve by creating an opening in the optic nerve sheath.

It is especially considered when:

• Vision is progressively worsening
• Papilledema is severe
• Medical treatment is insufficient
• Headache is not the dominant problem

ONSF Complications

Potential complications include:

• Diplopia
• Optic nerve injury
• Vascular injury
• Visual loss
• Recurrence of papilledema

CSF Diversion

Options include:

• Ventriculoperitoneal shunt
• Lumboperitoneal shunt

VP shunts are commonly favored in many centers.

Indications include:

• Progressive visual loss
• Medically refractory disease
• Fulminant IIH

Shunt Complications

Include:

• Obstruction
• Infection
• Migration
• Overdrainage
• Low-pressure headache
• Need for revision

Venous Sinus Stenting

Venous sinus stenting may be considered for selected patients with:

• Medically refractory IIH
• Significant venous sinus stenosis
• Demonstrable trans-stenotic pressure gradient
• Appropriate neurointerventional evaluation

It should not be performed simply because MRV shows sinus narrowing.

CVST Treatment

Cerebral venous sinus thrombosis generally requires:

Systemic anticoagulation

with management by:

• Neurology/stroke team
• Hematology when appropriate

Intracranial Mass

Treatment may include:

• Neurosurgery
• Oncology therapy
• Corticosteroids for vasogenic edema when appropriate
• CSF diversion

depending on etiology.

Meningitis

Requires urgent cause-specific antimicrobial treatment.

Papilledema in suspected meningitis increases concern about raised ICP and the safety of immediate lumbar puncture.

Pregnancy

IIH may occur or recur during pregnancy.

Management balances:

• Maternal vision
• Maternal health
• Fetal safety

Acetazolamide During Pregnancy

Older teaching recommended complete avoidance.

Modern practice is more individualized.

Acetazolamide is often:

• Avoided when possible during the first trimester
• Considered later, or earlier in vision-threatening disease, when benefits outweigh potential fetal risks

Care should be coordinated with:

• Obstetrics
• Neurology
• Neuro-ophthalmology

Surgical Treatment in Pregnancy

When vision is threatened, options may include:

• Optic nerve sheath fenestration
• CSF diversion
• Temporary lumbar puncture

depending on severity and gestational considerations.

Follow-Up

Follow-up frequency depends on:

• Frisén grade
• Visual field status
• Acuity
• Rate of change
• Treatment response

Severe or rapidly progressive disease may require review within:

Days to weeks

Monitoring

At follow-up, assess:

• Visual acuity
• Pupils
• Color vision
• Optic disc appearance
• OCT
• Automated visual fields
• Symptoms

Headache vs Papilledema

Headache and papilledema should be monitored separately.

A patient may have:

• Resolved papilledema
• Persistent migraine-like headache

Persistent headache alone does not necessarily indicate persistent raised ICP.

Patient Education

Patients should seek urgent reassessment for:

• New visual loss
• Increasing transient visual obscurations
• New diplopia
• Severe worsening headache
• Repeated vomiting
• Seizure
• Focal neurologic symptoms

Prognosis

Visual prognosis is generally excellent when:

• Papilledema is mild
• Visual fields are preserved
• The cause is treated promptly

Poor prognostic factors include:

• Severe papilledema
• Delayed treatment
• Rapid progression
• Significant field loss at presentation
• Optic atrophy

Complications

Potential complications include:

• Permanent visual field loss
• Reduced central acuity
• Optic atrophy
• Chronic headache
• Diplopia from CN VI palsy

Treatment-related complications include:

• Acetazolamide toxicity
• Post-LP headache
• CSF leak
• Shunt infection/failure
• ONSF complications
• Venous stent complications

Ophthalmology Pearls

• Papilledema = optic disc edema specifically due to raised intracranial pressure.
• It is usually bilateral but may be markedly asymmetric.
• True papilledema can indicate brain mass, CVST, hydrocephalus, meningitis, or other life-threatening disease.
• Early central acuity may remain normal; visual field testing is often more sensitive to early functional loss.
• The classic early field defect is enlargement of the blind spot.
• Transient visual obscurations, pulsatile tinnitus, and CN VI palsy are classic symptoms/signs of raised ICP.
• Loss of spontaneous venous pulsation is supportive but not diagnostic.
• MRI brain plus MRV/CTV should exclude mass lesion and venous sinus thrombosis before labeling a patient as IIH.
• After appropriate imaging, lumbar puncture confirms opening pressure and normal CSF composition.
• In adults, ≥25 cm H₂O supports elevated opening pressure when measured correctly.
• OCT is useful, but a falling RNFL thickness can reflect either resolution of edema or optic atrophy.
• In IIH, weight loss is the key disease-modifying treatment.
• Acetazolamide is the main medication used to protect vision in IIH.
• Routine long-term corticosteroids and serial lumbar punctures are generally not recommended for IIH.
• Fulminant IIH with rapidly declining vision requires urgent surgical consideration.
• An optic nerve that has become atrophic may stop swelling despite persistent high ICP, so “less swelling” does not always mean recovery.